Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceHigh levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in TanzaniaLow-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, AngolaIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialModelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.Intermittent preventive treatment of malaria in children: a qualitative study of community perceptions and recommendations in Burkina Faso and Mali.How well are malaria maps used to design and finance malaria control in Africa?Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaDrug resistance maps to guide intermittent preventive treatment of malaria in African infants.The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.Monitoring antifolate resistance in intermittent preventive therapy for malaria.Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication.Developing a novel risk prediction model for severe malarial anemia.
P2860
Q21032450-8395EE3F-2FDD-45C9-B76F-573FBEBF9938Q21033803-B2F358B8-5E06-46EF-823A-D97A22AA86D6Q28125937-9500926D-870B-488F-8944-02468EED45B2Q28481649-FD2F8735-5DBB-4389-BA3B-A22A6B75FD9FQ33886209-524C1328-9C42-4F70-A73D-59BA87A11DE1Q33948210-6BFB5A74-2A8B-4BD9-ADB6-192BBDFD6820Q34193509-4BAABAB9-4DB0-4AB9-B3F0-99F9A00450A2Q34551243-59133ECE-0150-493F-BB8F-150A78901AD6Q34596548-097B746B-481B-4103-A004-59BAADA20F37Q35228689-161629DF-855D-48CE-9FBF-5C7F5F39379FQ35941471-86F892CE-5922-4C73-B53E-8EDFD6262AC3Q36292865-B3D30B2B-5B53-4576-9C26-2C939B1544E9Q36840090-A96EAB43-F0A1-4DE6-93A0-D5B70E9D7377Q37260585-DBFB39BF-B9D3-471E-BD32-23A9B0E01A53Q37390524-3658C3E4-AD5D-40AE-9553-4C4BB787D224Q47132201-D43ED93E-A922-4018-B4D0-EA79E2A6CFFBQ51769989-51F81BBB-F6A5-45D2-856D-9BC7F10A91CC
P2860
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protective efficacy of intermi ...... amine and parasite resistance.
@ast
Protective efficacy of intermi ...... amine and parasite resistance.
@en
type
label
Protective efficacy of intermi ...... amine and parasite resistance.
@ast
Protective efficacy of intermi ...... amine and parasite resistance.
@en
prefLabel
Protective efficacy of intermi ...... amine and parasite resistance.
@ast
Protective efficacy of intermi ...... amine and parasite resistance.
@en
P2093
P2860
P50
P1433
P1476
Protective efficacy of intermi ...... amine and parasite resistance.
@en
P2093
David Schellenberg
Ilona Carneiro
Jamie T Griffin
Matthew Cairns
Robert D Newman
Roly D Gosling
P2860
P304
P356
10.1371/JOURNAL.PONE.0012618
P407
P577
2010-09-07T00:00:00Z